241 related articles for article (PubMed ID: 28575765)
1. The influence of levetiracetam on psychosocial and behavioral functioning in children: A case-control and follow-up study.
Bektaş G; Tekin U; Özkan MU; Yıldız EP; Çalışkan M; Özmen M; Aydınlı N
Epilepsy Behav; 2017 Jul; 72():39-42. PubMed ID: 28575765
[TBL] [Abstract][Full Text] [Related]
2. Irritability and its relationship with psychosocial symptoms and quality of life in adolescents with epilepsy receiving levetiracetam therapy: A case-control study.
Tekin U; Tekin E; Uçar HN
Epilepsy Behav; 2022 Oct; 135():108877. PubMed ID: 35985165
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review.
Lee YJ; Kim T; Bae SH; Kim YH; Han JH; Yun CH; Kim CY
CNS Drugs; 2013 Sep; 27(9):753-9. PubMed ID: 23921717
[TBL] [Abstract][Full Text] [Related]
4. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
6. Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
Zhang Q; Yang F; Hu Z; Zhang Z; Xu Q; Dante M; Wu H; Li Z; Li Q; Li K; Lu G
Eur Radiol; 2017 May; 27(5):2137-2145. PubMed ID: 27553940
[TBL] [Abstract][Full Text] [Related]
7. Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review.
Halma E; de Louw AJ; Klinkenberg S; Aldenkamp AP; IJff DM; Majoie M
Seizure; 2014 Oct; 23(9):685-91. PubMed ID: 24981629
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy.
Jung DE; Yu R; Yoon JR; Eun BL; Kwon SH; Lee YJ; Eun SH; Lee JS; Kim HD; Nam SO; Kim GH; Hwang SK; Eom S; Kang DR; Kang HC
Neurology; 2015 Jun; 84(23):2312-9. PubMed ID: 25948717
[TBL] [Abstract][Full Text] [Related]
9. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
10. Effects of valproic acid and levetiracetam monotherapy on carotid intima-media and epicardial adipose tissue thickness in non-obese children with epilepsy.
Karatoprak E; Tosun O
Brain Dev; 2020 Feb; 42(2):165-170. PubMed ID: 31806254
[TBL] [Abstract][Full Text] [Related]
11. Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study.
Kowski AB; Weissinger F; Gaus V; Fidzinski P; Losch F; Holtkamp M
Epilepsy Behav; 2016 Jan; 54():150-7. PubMed ID: 26709103
[TBL] [Abstract][Full Text] [Related]
12. Continuation rates of levetiracetam in children from the EULEVp cohort study.
Dureau-Pournin C; Pédespan JM; Droz-Perroteau C; Lavernhe G; Mann M; Pollet C; Robinson P; Jové J; Moore N; Fourrier-Réglat A;
Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
14. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
15. [Levetiracetam in the treatment of epilepsy].
Mariero Klees T; Brodtkorb E; Nakken KO; Lossius R; Johannessen SI
Tidsskr Nor Laegeforen; 2003 May; 123(11):1539-41. PubMed ID: 12822020
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
Mink S; Muroi C; Seule M; Bjeljac M; Keller E
Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
[TBL] [Abstract][Full Text] [Related]
17. A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy.
Nakken KO; Eriksson AS; Lossius R; Johannessen SI
Seizure; 2003 Jan; 12(1):42-6. PubMed ID: 12495648
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of levetiracetam because of behavioral side effects: a case-control study.
White JR; Walczak TS; Leppik IE; Rarick J; Tran T; Beniak TE; Matchinsky DJ; Gumnit RJ
Neurology; 2003 Nov; 61(9):1218-21. PubMed ID: 14610123
[TBL] [Abstract][Full Text] [Related]
19. Haematological side effects of antiepileptic drug treatment in patients with epilepsy.
Bachmann T; Bertheussen KH; Svalheim S; Rauchenzauner M; Luef G; Gjerstad L; Taubøll E
Acta Neurol Scand Suppl; 2011; (191):23-7. PubMed ID: 21711253
[TBL] [Abstract][Full Text] [Related]
20. Effects of levetiracetam and valproic acid monotherapy on sex-steroid hormones in prepubertal children--results from a pilot study.
Rauchenzauner M; Bitsche G; Svalheim S; Tauboll E; Haberlandt E; Wildt L; Rostasy K; Luef G
Epilepsy Res; 2010 Feb; 88(2-3):264-8. PubMed ID: 20015617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
